Fundraising Fox
bioio
Founded 2019 · 4 employees on LinkedIn · 4 known investors
Find your way into bioio
Sign up to see every warm intro you have to bioio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the bioio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
Founders & leadership
bioio was founded in 2019 by Dr. Peterson.
DP
Dr. Peterson
Investors · 4
BioGenerator Ventureslisted by BioGenerator VenturesSt. Louis · $50K – $250K
How we know: BioGenerator Ventures's portfolio page · Not right? Tell us
Lifespan Vision Ventureslisted by Lifespan Vision VenturesNorwalk
How we know: Lifespan Vision Ventures's portfolio page · Not right? Tell us
Related companies · 6
iBioiBio is a biopharmaceutical company with leadership experienced in drug discovery, development, and clinical operations across multiple therapeutic areas. The company appears to focus on innovative therapeutics and biologics development.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
PercipioPercipio Health helps independent primary care practices claim Advanced Primary Care Management (APCM) reimbursements from Medicare that most practices do not yet operationalize. The company focuses on capturing unclaimed revenue for small independent primary care physician groups.
IndieBioIndieBio was a startup accelerator and pre-seed investment program launched by SOSV in San Francisco in 2015, providing on-site bio-labs and funding to science founders across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics. As of 2026 the program was rebranded to SOSV NY and SOSV SF, expanding its focus from bio to broader deep tech.
BodyBioBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
Companies working in the same space as bioio.
Frequently asked questions
- What does bioio do?
- BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
- Who founded bioio?
- bioio was founded by Dr. Peterson in 2019.
- Who are bioio's investors?
- bioio's investors include BioGenerator Ventures, Lifespan Vision Ventures, Missouri Technology Corporation, quadraScope Venture Fund.